6,001 reports of this reaction
2.3% of all Spiriva reports
#7 most reported adverse reaction
WHEEZING is the #7 most commonly reported adverse reaction for Spiriva, manufactured by Boehringer Ingelheim Pharmaceuticals, Inc.. There are 6,001 FDA adverse event reports linking Spiriva to WHEEZING. This represents approximately 2.3% of all 266,551 adverse event reports for this drug.
Patients taking Spiriva who experience wheezing should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WHEEZING is a less commonly reported adverse event for Spiriva, but still significant enough to appear in the safety profile.
In addition to wheezing, the following adverse reactions have been reported for Spiriva:
The following drugs have also been linked to wheezing in FDA adverse event reports:
WHEEZING has been reported as an adverse event in 6,001 FDA reports for Spiriva. This does not prove causation, but indicates an association observed in post-market surveillance data.
WHEEZING accounts for approximately 2.3% of all adverse event reports for Spiriva, making it a notable side effect.
If you experience wheezing while taking Spiriva, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.